Mesalazine granule formulation improves clinical data in Crohn's disease compared with tablet formulation

The efficacy of sustained-release preparations of mesalazine as a remission maintenance treatment for Crohn's disease remains to be established. We aimed to examine the changes in compliance rate and clinical data 2 years after switching from mesalazine tablet to granule formulation at our faci...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamura, Satoshi, Ishida, Natsuki, Miyazu, Takahiro, Onoue, Shunya, Tani, Shinya, Yamade, Mihoko, Hamaya, Yasushi, Iwaizumi, Moriya, Osawa, Satoshi, Furuta, Takahisa, Sugimoto, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721736/
https://www.ncbi.nlm.nih.gov/pubmed/33288852
http://dx.doi.org/10.1038/s41598-020-78603-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721736/
https://www.ncbi.nlm.nih.gov/pubmed/33288852
http://dx.doi.org/10.1038/s41598-020-78603-9

Ejemplares similares